Lori Krim Gough Ph.D.


Lori has more than 22 years of experience in drug discovery and business development across the biotech and pharmaceutical industry.

Prior to joining Epidarex, Lori served as the Chief Business & Strategy Officer of NeuExcell Therapeutics.  In this role she was responsible for developing and executing corporate partnering and financing strategies.  She was also accountable for the company’s $200 million partnership with Spark Therapeutics, portfolio prioritization and external communications.

Lori previously served as the VP of Corporate Development at Tmunity Therapeutics, a cell therapy spin-out from UPenn, that has since been acquired by Kite Pharma.  During her three years at Tmunity, Lori led the business development strategy for in-licensing, drove external innovation efforts and managed complex strategic partnerships. 

Lori also spent five years at GSK where she held diverse leadership roles across multiple groups including Strategy and Portfolio, Discovery Partnerships with Academia (DPAc) and Platform and Technology Business Development.

Earlier in her career, Lori spent 12 years in drug discovery at Wyeth/Pfizer. During this time, Lori led several successful multi-disciplinary teams in her role as a medicinal chemist, and advanced multiple molecules into clinical development.  Her work ranged from target identification to clinical candidate and spanned across multiple therapeutic areas. She has authored more than a dozen publications and is a named inventor on 18 patents.

Lori chaired the prestigious Medicinal Chemistry Gordon Research Conference, served on the Long-Range Planning Committee for the ACS MEDI Division and is currently part of the ACS Executive Board serving as Industrial Councilor.  Lori also serves on the Boards of the Chemistry Department at the University of Pennsylvania, the Coulter Translational Drug Discovery Program at Drexel University, and the Philadelphia-Israel Chamber of Commerce.

Lori graduated Summa Cum Laude from Colgate University and earned her Ph.D. in Organic Chemistry at the University of Pennsylvania.